Zealand Pharma is a prominent, mid-to-large-cap global biotechnology enterprise with a multi-billion-dollar market capitalization, reflecting its substantial footprint in peptide-based drug discovery and metabolic disease therapeutics. Headquartered in Denmark with an active international presence, the company employs hundreds of specialized scientists, clinical researchers, and corporate professionals, maintaining robust research collaborations with major pharmaceutical partners to advance its innovative pipeline toward commercialization.